Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

HHCVHexahydrocannabivarin

Semi-synthetic propyl homologue of HHC (hydrogenated THCV), 9R and 9S epimers; pharmacology not measured.

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₁₉H₂₈O₂

CID 175224406

Family
Semi-synthetic cannabinoidHydrogenated
Molar mass
288.43 g/mol

Updated on

In plain terms

Hexahydrocannabivarin (HHCV) is the short-chain version of HHC, made by hydrogenating THCV. Neither its potency nor its effects in humans are known. In France, it is classed as a narcotic by the 2024 generic clause.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    Hexahydrocannabivarin is the propyl-chain homologue of hexahydrocannabinol, in other words hydrogenated tetrahydrocannabivarin (THCV). Saturating the terpenoid ring creates a stereocentre at position 9 and therefore two epimers, 9R and 9S. Homologous series of hexahydrocannabinols were compared in dogs as early as 1942 by Adams et al., and HHCV appears no later than 1972 in a gas chromatography study (Vree et al.). No cannabinoid receptor binding measurement has been published. In human liver microsomes, both epimers were metabolised by hydroxylation, dehydrogenation, ketone formation and carboxylation; for the 9S epimer, the main metabolite was hydroxylated on the methylcyclohexyl ring, as for HHC (Watanabe et al. 2025). No human pharmacokinetic or toxicology data exist. In France, it has fallen under the benzo[c]chromene generic class since June 2024.

    Key sources.

    History

    Source
    Semi-synthetic compound with no documented presence in the plant. It corresponds to hydrogenated tetrahydrocannabivarin (THCV); the EMCDDA (2023) notes that hydrogenating hemp extracts to make HHC can also convert the other cannabinoids present, THCV among them, into little-studied hydrogenated derivatives.

    Route of preparation

    Chemical process

    No plant enzymatic pathway. It is the hydrogenated derivative of THCV: saturating the double bond of the terpenoid ring creates a stereocentre at position 9, hence two epimers, 9R and 9S. Described here by chemical class only.

    Classification

    Family, origin and source verification

    Family

    Semi-synthetic cannabinoid › Hydrogenated

    Chemistry

    C3 side chain · neutral form

    Verification

    Every fact on this entry was checked against its primary sources on 20 October 2026.

    Wikipedia (English)

    Hexahydrocannabivarin (new tab)

    Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

    References

    1. Adams R, Loewe S, Smith CM, McPhee WD. Tetrahydrocannabinol homologs and analogs with marihuana activity. XIII. J Am Chem Soc 1942;64:694-697 (cited by the EMCDDA 2023) (new tab)
    2. Vree TB, Breimer DD, van Ginneken CA, van Rossum JM. Gas chromatography of cannabis constituents and their synthetic derivatives. J Chromatogr 1972;74:209-24 (includes HHCV, according to the EMCDDA 2023) (new tab)PMID 4645669
    3. EMCDDA (Ujváry I. et al.), Hexahydrocannabinol (HHC) and related substances, technical report, 2023 (new tab)
    4. Ujváry I. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: a comprehensive review. Drug Test Anal 2024;16:127-161 (new tab)PMID 37269160
    5. Watanabe S, Murakami T, Muratsu S, Saito T, Seto Y. In vitro metabolic profiling of 18 semi-synthetic cannabinoids, hexahydrocannabinol (HHC) and its analogs, with identification in an authentic HHCP urine sample. Clin Chem 2025;71:1158-1168 (new tab)PMID 40853012
    6. PubChem CID 175224406, (6aR,10aR)-6,6,9-trimethyl-3-propyl-hexahydrobenzo[c]chromen-1-ol (C9 undefined) (new tab)
    7. ANSM, decision of 22 May 2024 amending the list of substances classified as narcotics (generic benzo[c]chromene class), supplemented by the decision of 3 June 2024 (new tab)
    8. ANSM, decision of 12 June 2023 amending the list of substances classified as narcotics (HHC, HHC-acetate, HHCP) (new tab)
    9. ANSM, decision of 16 January 2026 amending the list of substances classified as narcotics (HHC in annex III) (new tab)
    10. ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (new tab)

    Identifiers

    Names

    Common name
    Hexahydrocannabivarin
    IUPAC name
    (6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol
    Other names
    HHCV · HHC-V · hexahydrocannabivarine

    Identifiers

    Formula
    C₁₉H₂₈O₂
    InChIKey
    QYNCMPYNYFYQFE-JENMUQSASA-N
    SMILES
    CCCc1cc2OC(C)(C)[C@@H]3CCC(C)C[C@H]3c2c(O)c1

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.